The Gazette from Montreal, Quebec, Quebec, Canada on September 22, 2000 · 52
4'-Hydroxychalcone | ≥99%(HPLC) | Selleck | NF-κB inhibitor
Activation of ERK1/2 and IkBa by RANKL and M-CSF in mature OCs. Mature... | Download Scientific Diagram
Caffeic Acid Phenethyl Ester | ≥99%(HPLC) | Selleck | NF-κB inhibitor
A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway | SpringerLink
Krystal Augustine (@Krystalizing) / Twitter
Cornuside | ≥99%(HPLC) | Selleck | NF-κB inhibitor
A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway | SpringerLink
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations | Science Immunology
E/Z)-IT-603 | ≥99%(HPLC) | Selleck | NF-κB inhibitor
Maslinic acid | ≥99%(HPLC) | Selleck | NF-κB inhibitor
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations | Science Immunology
ABSTRACT BOOK
Dauricine | ≥99%(HPLC) | Selleck | NF-κB inhibitor
8-O-acetyl shanzhiside methyl ester | ≥99%(HPLC) | Selleck | NF-κB inhibitor
NIK SMI1 | NF-κB Inhibitor | MedChemExpress
SynInnova Laboratories Inc.
QNZ (EVP4593) | ≥99%(HPLC) | Selleck | NF-κB inhibitor
SynInnova Laboratories Inc.
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations | Science Immunology
Tectochrysin | ≥99%(HPLC) | Selleck | NF-κB inhibitor
Chitosan oligosaccharide | ≥99%(HPLC) | Selleck | NF-κB inhibitor
Andrographolide | ≥99%(HPLC) | Selleck | NF-κB inhibitor
NIK SMI1 |CAS:1660114-31-7 Probechem Biochemicals
NIK (NF-κB-inducing kinase) Inhibitors - Kinase Inhibitors - Chemietek
Immunodeficiency, autoimmunity, and increased risk of B cell malignancy in humans with TRAF3 mutations | Science Immunology
